Prostate cancer

The genomic and epigenomic landscape of double-negative metastatic prostate cancer
The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
An integrated functional and clinical genomics approach reveals genes driving aggressive metastatic prostate cancer
Autoantibody landscape in patients with advanced prostate cancer
Deep Genomic Signature for early metastasis prediction in Prostate Cancer
Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer